SUN PHARMA ADV. RES. | UNIVERSUS PHOTO IMAGINGS | SUN PHARMA ADV. RES./ UNIVERSUS PHOTO IMAGINGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -26.4 | 1.4 | - | View Chart |
P/BV | x | - | 0.5 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SUN PHARMA ADV. RES. Mar-21 |
UNIVERSUS PHOTO IMAGINGS Mar-21 |
SUN PHARMA ADV. RES./ UNIVERSUS PHOTO IMAGINGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 210 | 253 | 82.8% | |
Low | Rs | 95 | 47 | 201.9% | |
Sales per share (Unadj.) | Rs | 9.7 | 42.9 | 22.5% | |
Earnings per share (Unadj.) | Rs | -5.8 | 13.0 | -44.3% | |
Cash flow per share (Unadj.) | Rs | -5.4 | 13.5 | -39.6% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -6.4 | 1,010.9 | -0.6% | |
Shares outstanding (eoy) | m | 262.05 | 10.95 | 2,393.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 15.8 | 3.5 | 450.4% | |
Avg P/E ratio | x | -26.4 | 11.5 | -229.0% | |
P/CF ratio (eoy) | x | -28.4 | 11.1 | -256.2% | |
Price / Book Value ratio | x | -23.7 | 0.1 | -15,962.5% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 39,871 | 1,643 | 2,426.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 916 | 25 | 3,717.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 2,530 | 470 | 538.7% | |
Other income | Rs m | 54 | 114 | 47.3% | |
Total revenues | Rs m | 2,584 | 584 | 442.4% | |
Gross profit | Rs m | -1,350 | 79 | -1,711.4% | |
Depreciation | Rs m | 109 | 5 | 2,007.9% | |
Interest | Rs m | 107 | 0 | 532,500.0% | |
Profit before tax | Rs m | -1,511 | 188 | -804.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 45 | 0.0% | |
Profit after tax | Rs m | -1,511 | 143 | -1,059.7% | |
Gross profit margin | % | -53.4 | 16.8 | -317.7% | |
Effective tax rate | % | 0 | 24.1 | 0.0% | |
Net profit margin | % | -59.7 | 30.4 | -196.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 631 | 1,644 | 38.4% | |
Current liabilities | Rs m | 2,334 | 23 | 10,185.6% | |
Net working cap to sales | % | -67.3 | 345.3 | -19.5% | |
Current ratio | x | 0.3 | 71.8 | 0.4% | |
Inventory Days | Days | 111 | 8,553 | 1.3% | |
Debtors Days | Days | 254 | 119 | 213.2% | |
Net fixed assets | Rs m | 1,666 | 9,553 | 17.4% | |
Share capital | Rs m | 262 | 109 | 239.4% | |
"Free" reserves | Rs m | -1,945 | 10,960 | -17.7% | |
Net worth | Rs m | -1,683 | 11,070 | -15.2% | |
Long term debt | Rs m | 1,167 | 0 | - | |
Total assets | Rs m | 2,297 | 11,197 | 20.5% | |
Interest coverage | x | -13.2 | 9,390.5 | -0.1% | |
Debt to equity ratio | x | -0.7 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0 | 2,626.0% | |
Return on assets | % | -61.2 | 1.3 | -4,801.2% | |
Return on equity | % | 89.8 | 1.3 | 6,971.8% | |
Return on capital | % | 272.6 | 1.7 | 16,067.1% | |
Exports to sales | % | 0 | 4.5 | 0.0% | |
Imports to sales | % | 0 | 41.3 | 0.0% | |
Exports (fob) | Rs m | NA | 21 | 0.0% | |
Imports (cif) | Rs m | NA | 194 | 0.0% | |
Fx inflow | Rs m | 120 | 21 | 570.7% | |
Fx outflow | Rs m | 2,141 | 194 | 1,104.1% | |
Net fx | Rs m | -2,021 | -173 | 1,169.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1,519 | 557 | -272.7% | |
From Investments | Rs m | 16 | -824 | -1.9% | |
From Financial Activity | Rs m | 1,593 | NA | -7,964,200.0% | |
Net Cashflow | Rs m | 90 | -267 | -33.5% |
Indian Promoters | % | 69.1 | 74.6 | 92.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 3.2 | 0.0 | - | |
FIIs | % | 2.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 30.9 | 25.5 | 121.5% | |
Shareholders | 94,494 | 29,837 | 316.7% | ||
Pledged promoter(s) holding | % | 2.2 | 0.0 | - |
Compare SUN PHARMA ADV. RES. With: VA TECH WABAG RATTANINDIA ENTERPRISES QUESS CORP TEAMLEASE SERVICES HEALTHCARE GLOBAL ENTER.
Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.